News

Zotefoams announces licensing agreement with Censco for manufacture of microcellular foaming equipment

Zotefoams maintains focus on ReZorce® mono-material barrier packaging while benefitting from Censco’s ability to increase capacity and reduce lead times for critical equipment.

Zotefoams, a world leader in cellular materials technology, has announced an agreement where Censco LLC will manufacture under licence the proprietary gas injection equipment marketed by Zotefoams under the MuCell® brand.

Previously produced in-house by Zotefoams’ MuCell Extrusion LLC business unit based in Woburn, Massachusetts, the equipment is installed on plastic extrusion lines to inject atmospheric gases during the melt phase. Over the past five years, Zotefoams has harnessed MuCell technology to create ReZorce, its disruptive mono-material barrier packaging range, and this agreement will allow it to further focus efforts on the significant opportunities that ReZorce offers in replacing difficult-to-recycle composite materials.

Headquartered in Lowell, Massachusetts and with additional facilities in Mexico and Colombia, Censco has been offering a full range of services engineering, manufacturing and aftermarket for over 20 years and has an established roster of customers worldwide. The two companies are now engaged in a technology transfer exercise and expect Censco to assume production in the fourth quarter of this year.


Latest Updates

News Centre

News

Ventco by Lakeside partners with Zotefoams North America to expand access to world-leading foam technologies in the construction sector

Read More

News

Zotefoams accelerates innovation capabilities with new announcements

Read More

News

Zotefoams enters Joint Venture with Seoheung Co. Ltd

Read More